Shanghai Bono Biotechnology Shines in CPHI 2025, Interpreting the New Paradigm of Pharmaceutical Equipment with Innovative Technology

The 23rd CPHI China and the 18th PMEC China will be held grandly at the Shanghai New International Expo Center from June 24th to 26th, 2025. As a barometer of the Asian pharmaceutical industry, this exhibition brings together nearly 3500 companies and over 100000 professional visitors, focusing on innovative achievements in the entire pharmaceutical industry chain. Shanghai Bono Biotechnology Co., Ltd. (booth number: W11A19) showcased its core products and won industry attention with breakthrough technological achievements, further consolidating its position in the field of pharmaceutical pretreatment equipment.

Top tier product matrix, addressing industry pain points

Shanghai Bono showcased three core equipment, targeting the efficiency improvement and intelligence needs in the fields of pharmaceuticals and life sciences:

1. T-frame vacuum freeze dryerSpecially designed for high demand samples, equipped with 28 independent sealed valves, imported compressors (multi temperature range from -65 ℃ to -110 ℃), and a 25L large capacity condenser. The coil condenser and material pipeline separation technology effectively prevent cross contamination and are suitable for sensitive samples such as bacteria and peptides; Intelligent control is achieved through a 10 inch touch screen, supporting real-time monitoring and remote IoT control, greatly improving laboratory efficiency.

2. Vacuum freeze concentratorFor the development of thermosensitive biological samples, a wide temperature range of -10~100 ℃ and meticulous temperature control technology are adopted to avoid loss of sample activity. The integrated anti-corrosion centrifugal chamber combined with AC variable frequency motor achieves maintenance free operation with a noise level below 65 decibels, providing a reliable low loss concentration solution for biopharmaceuticals.

3. BIONOON series vacuum centrifugal concentratorIntegrating centrifugal force, vacuum, and heating technologies to support high-throughput sample processing. Its centrifugal imaging system can observe the sample status in real-time during operation, solving the problem of splashing and cross contamination in traditional concentration processes, and is widely used in RNA/DNA research, toxicology identification and other fields.

Technological advantages drive market recognition

During the exhibition, Shanghai Bono's booth attracted a large number of domestic and foreign experts, distributors, and end customers. Its products have received high praise based on three core advantages:

l Efficiency improvement and low lossVacuum low-temperature technology ensures sample activity and increases concentration efficiency by over 30%;

l intelligent operationThe self-developed BIONOON operating system supports one click start stop and data tracing, reducing manual intervention;

l modular designThe device supports customized accessories (such as gradient vacuum systems, specialized rubber valves) and is suitable for diverse experimental scenarios.

Deepen cooperation and lay out an innovative ecosystem

As a company that has been deeply involved in life science instruments for more than ten years, Shanghai Bono has always adhered to the concept of "creating value for customers". This exhibition not only showcases technological strength, but also actively seeks strategic cooperation with research institutes and biopharmaceutical companies. The company has established deep research and development relationships with multiple universities at home and abroad, and its equipment has been deployed in batches to domestic pharmaceutical companies to assist in batch testing and production needs. In the future, Shanghai Bono will continue to invest in research and development, promote the development of domestically produced high-quality instruments overseas, and fulfill the brand mission of "extraordinary commitment".

Conclusion
CPHI&PMEC China 2025 has witnessed the rise of Chinese pharmaceutical equipment enterprises, and Shanghai Bono Biotechnology injects new momentum into the global pharmaceutical industry chain with innovation as the engine. Its technological achievements not only demonstrate the global competitiveness of domestic equipment, but also foreshadow the future prospects of intelligent pharmaceutical industry.